Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

GHRS

GH Research PLC

Dec 12 • 11:18AM ET

8.05

Dollar change -0.55
Percentage change -6.39	%

Healthcare • Biotechnology • Ireland • NASD

Peers: NBIX EXEL CORT SAGE ALT AGIO URGN VKTX MNKD PRTA

| Held by: SBIO ONEQ PSIL EIRL GWX

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.80	Insider Own	41.49%	Shs Outstand	52.03M	Perf Week	0.63%
Market Cap	418.83M	Forward P/E	-	EPS next Y	-1.11	Insider Trans	0.00%	Shs Float	30.44M	Perf Month	-12.02%
Income	-41.43M	PEG	-	EPS next Q	-0.22	Inst Own	57.82%	Short Float	6.51%	Perf Quarter	-3.01%
Sales	0.00M	P/S	-	EPS this Y	-16.91%	Inst Trans	0.93%	Short Ratio	32.54	Perf Half Y	-36.36%
Book/sh	3.64	P/B	2.21	EPS next Y	-39.37%	ROA	-19.17%	Short Interest	1.98M	Perf Year	35.52%
Cash/sh	2.88	P/C	2.79	EPS next 5Y	-	ROE	-19.96%	52W Range	5.05 - 14.99	Perf YTD	38.79%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-253.12%	ROI	-21.83%	52W High	-46.30%	Beta	0.78
Dividend TTM	-	Quick Ratio	15.83	Sales past 5Y	0.00%	Gross Margin	-	52W Low	59.41%	ATR (14)	0.86
Dividend Ex-Date	-	Current Ratio	15.83	EPS Y/Y TTM	-1.28%	Oper. Margin	-	RSI (14)	43.18	Volatility	11.72% 10.63%
Employees	49	Debt/Eq	0.00	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	29.80
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	-114.36%	Payout	-	Rel Volume	0.74	Prev Close	8.60
Sales Surprise	-	EPS Surprise	6.50%	Sales Q/Q	-	Earnings	Nov 14 BMO	Avg Volume	60.93K	Price	8.05
SMA20	-9.94%	SMA50	-2.57%	SMA200	-21.20%	Trades		Volume	14,096	Change	-6.39%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-16-22	Initiated	H.C. Wainwright	Buy	$45
Jun-16-22	Initiated	ROTH Capital	Buy	$66

Nov-20-24 09:55AM	Does GH Research (GHRS) Have the Potential to Rally 225.18% as Wall Street Analysts Expect? (Zacks) +13.94%
Nov-18-24 07:19AM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
Nov-14-24 07:00AM	GH Research Reports Third Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire)
Sep-09-24 12:00PM	GH Research (GHRS) Moves to Buy: Rationale Behind the Upgrade (Zacks)
09:35AM	After Plunging -18.19% in 4 Weeks, Here's Why the Trend Might Reverse for GH Research (GHRS) (Zacks)
09:14PM	Loading…
Sep-08-24 09:14PM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
Sep-03-24 07:05AM	GH Research Reports Second Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire) -6.57%
07:00AM	GH Research Announces Appointment of Dr. Velichka "Villy" Valcheva to Chief Executive Officer (GlobeNewswire)
Jul-06-24 07:21AM	3 Psychedelic Stocks to Ride to the Moon and Beyond (InvestorPlace)
Jul-03-24 09:48AM	Psychedelic Picks: 3 Trippy Stocks Aiming for Out-of-This-World Returns (InvestorPlace)
May-13-24 08:50AM	Recent Price Trend in GH Research (GHRS) is Your Friend, Here's Why (Zacks)
May-10-24 09:55AM	Wall Street Analysts Predict a 166.89% Upside in GH Research (GHRS): Here's What You Should Know (Zacks) +6.84%
May-03-24 01:53PM	GHRS Stock Earnings: GH Research Beats EPS for Q1 2024 (InvestorPlace)
07:00AM	GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire)
Mar-05-24 09:55AM	How Much Upside is Left in GH Research PLC (GHRS)? Wall Street Analysts Think 321.28% (Zacks)
07:00AM	Loading…
Feb-29-24 07:00AM	GH Research Reports Full Year 2023 Financial Results and Provides Business Updates (GlobeNewswire) +7.90%
Jan-18-24 04:30PM	GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression (GlobeNewswire)
Jan-16-24 09:55AM	Can GH Research PLC (GHRS) Climb 488.72% to Reach the Level Wall Street Analysts Expect? (Zacks)
Dec-29-23 08:47AM	11 Best Psychedelic Stocks to Buy in 2024 (Insider Monkey)
Dec-20-23 02:15PM	11 Most Promising Psychedelic Stocks According to Hedge Funds (Insider Monkey) -7.32%
Dec-19-23 11:07AM	15 Best Falling Stocks To Buy Now (Insider Monkey) +9.13%
Nov-09-23 04:45PM	GH Research Reports Third Quarter Financial Results and Provides Business Updates (GlobeNewswire)
Sep-29-23 04:45PM	GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression (GlobeNewswire)
Aug-23-23 07:00AM	GH Research Reports Second Quarter 2023 Financial Results and Provides Business Updates (GlobeNewswire)
Jul-17-23 11:53AM	Here's Why We're Not Too Worried About GH Research's (NASDAQ:GHRS) Cash Burn Situation (Simply Wall St.)
Jul-06-23 09:40AM	Its Really a Brain Chemistry Issue: Elon Musk Embraces Ketamine in the Battle Against Depression Here Are 2 Psychedelic Stocks That Analysts Like (TipRanks)
Jun-29-23 08:00AM	The 3 Best Psychedelic Stocks to Buy Now (InvestorPlace)
May-11-23 07:30AM	GH Research Reports First Quarter 2023 Financial Results and Provides Business Highlights (GlobeNewswire)
Mar-23-23 01:56PM	Down More Than 50%: 2 Strong Buy Stocks That Are Too Cheap to Ignore (TipRanks) +14.78%
Mar-12-23 12:22PM	10 Best Psychedelic Stocks to Buy According to Hedge Funds (Insider Monkey)
07:00AM	Loading…
Mar-02-23 07:00AM	GH Research Reports Full Year 2022 Financial Results and Provides Business Updates (GlobeNewswire)
Feb-07-23 10:15AM	GH Research (NASDAQ:GHRS) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.)
Jan-09-23 07:30AM	GH Research Provides Business Updates and Highlights Key Upcoming Milestones (GlobeNewswire) -13.00%
Nov-21-22 12:22PM	7 Short-Squeeze Stocks for Bold Contrarians to Consider (InvestorPlace) -6.67%
Nov-10-22 07:05AM	GH Research Reports Third Quarter 2022 Financial Results and Provides Business Updates (GlobeNewswire) +7.03%
Sep-14-22 09:55AM	Wall Street Analysts See a 262% Upside in GH Research PLC (GHRS): Can the Stock Really Move This High? (Zacks) +9.26%
Aug-30-22 03:02PM	7 Psychedelics Stocks to Buy for a Big Drug Boom (InvestorPlace) -6.01%
Aug-29-22 09:55AM	Wall Street Analysts Predict a 206% Upside in GH Research PLC (GHRS): Here's What You Should Know (Zacks) +7.95%
Aug-23-22 07:00AM	GH Research Reports Second Quarter 2022 Financial Results and Provides Business Updates (GlobeNewswire) +5.33%
May-18-22 07:00AM	GH Research Reports First Quarter 2022 Financial Results and Provides Business Updates (GlobeNewswire) -9.98%
Mar-28-22 07:04AM	GH Research Reports Full Year 2021 Financial Results and Provides Business Updates (GlobeNewswire)
Mar-24-22 11:48AM	We're Not Very Worried About GH Research's (NASDAQ:GHRS) Cash Burn Rate (Simply Wall St.)
Dec-06-21 07:10AM	GH Research Reports Third Quarter 2021 Financial Results and Provides Business Updates (GlobeNewswire) +21.86%
07:00AM	GH Research Announces Successful Outcome of the Phase 2 part of its Phase 1/2 Clinical Trial of GH001 in Treatment-Resistant Depression (GlobeNewswire)
Oct-27-21 04:50AM	10 Pharma Stocks to Buy According to Mark Lamperts Biotechnology Value Fund (Insider Monkey) +10.61%
Sep-25-21 10:07AM	We Think GH Research (NASDAQ:GHRS) Can Afford To Drive Business Growth (Simply Wall St.)
Sep-23-21 05:25PM	GH Research PLC Provides Business Updates and Reports Second Quarter 2021 Financial Results (GlobeNewswire)
Jul-02-21 04:20PM	Psyched: GH Research Debuts on Nasdaq, Compass Reaches Psilocybin Research Milestone, Maxim Gives BUY Rating to 10 Psychedelics Companies (Benzinga) -5.64%
Jun-25-21 01:23PM	7 Companies Go Public Today. What Investors Need to Know. (Barrons.com)

GH Research Plc operates as a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients of psychiatric and neurological disorders. The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Schonharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GHRS

GH Research PLC

Upgrade your FINVIZ experience